ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Blood Products Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-3Y15116
Home | Market Reports | Health| Pharmacy
Global Human Blood Products Market Insights Forecast to 2029
BUY CHAPTERS

Global Human Blood Products Market Research Report 2025

Code: QYRE-Auto-3Y15116
Report
March 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Octapharma AG
Grifols S A
Hualan Bio
BPL
Takeda
CSL Limited
Kedrion S p A
LFB Group
Biotest
RAAS
CBPO
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics

Human Blood Products Market Size

The global market for Human Blood Products was valued at US$ 35330 million in the year 2024 and is projected to reach a revised size of US$ 58200 million by 2031, growing at a CAGR of 7.5% during the forecast period.

Human Blood Products Market

Human Blood Products Market

Human Blood Products are medical products derived from human blood and used for the treatment of various conditions. They include whole blood, blood components like red blood cells, platelets, and plasma, as well as plasma derivatives such as clotting factors and immunoglobulins. Human Blood Products are essential in medical treatments, including surgeries, trauma care, and for patients with blood disorders, anemia, or immune deficiencies.
Market Drivers:
Increasing Demand for Plasma-Derived Therapies: The rising prevalence of chronic diseases, such as immune deficiencies, hemophilia, and autoimmune disorders, has led to increased demand for plasma-derived products like immunoglobulins, clotting factors, and albumin, driving the Blood Plasma Product market.
Aging Population: The global aging population is more prone to chronic diseases and conditions requiring plasma-derived therapies, contributing to the growth of the Blood Plasma Product market.
Growing Use of Immunoglobulins: Immunoglobulins are increasingly used in the treatment of a wide range of diseases, including primary and secondary immune deficiencies, boosting the need for Blood Plasma Product to produce these therapies.
Rising Healthcare Expenditure and Improved Healthcare Access: Expanding healthcare infrastructure in developing countries, combined with rising healthcare expenditure, is driving demand for advanced medical treatments and plasma-derived products.
Market Challenges:
High Costs of Plasma-Derived Products: The complex and time-consuming process of Blood Plasma Product leads to high costs for plasma-derived products, making these treatments less accessible, particularly in low-income regions.
Limited Plasma Supply: The availability of plasma for fractionation is often limited by low donation rates, regulatory restrictions, and the lengthy process of screening and collecting plasma, leading to supply shortages.
Stringent Regulatory Framework: Blood Plasma Product is subject to rigorous regulatory requirements to ensure safety and efficacy. Meeting these regulations can increase development costs and slow the introduction of new products to the market.
Complex Manufacturing Process: The Blood Plasma Product process is technically challenging and requires significant investment in infrastructure, equipment, and skilled labor, posing barriers for new entrants and smaller manufacturers.
The outbreak of COVID-19 pandemic has led to decrease in number of blood donations and plasma collections, which hampers the market growth as it leads to shortage in raw material supply.
The classification of Blood Plasma Product includes Immune Globulin, Coagulation Factor, Albumin and Other. In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Product market.
North America is the largest consumption place, with a revenue market share nearly 40% in 2023. Following North America, Europe is the second largest consumption place with the revenue market share of 24 %; China is also an important sales region for the Blood Plasma Product.
This report aims to provide a comprehensive presentation of the global market for Human Blood Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Blood Products.
The Human Blood Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Blood Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Blood Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Blood Products Market Report

Report Metric Details
Report Name Human Blood Products Market
Accounted market size in year US$ 35330 million
Forecasted market size in 2031 US$ 58200 million
CAGR 7.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Other
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Human Blood Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Human Blood Products Market growing?

Ans: The Human Blood Products Market witnessing a CAGR of 7.5% during the forecast period 2025-2031.

What is the Human Blood Products Market size in 2031?

Ans: The Human Blood Products Market size in 2031 will be US$ 58200 million.

What is the Human Blood Products Market share by type?

Ans: In 2023, Immune Globulin accounted for a share of 51% in the global Blood Plasma Product market.

What is the Human Blood Products Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 40% in 2023.

Who are the main players in the Human Blood Products Market report?

Ans: The main players in the Human Blood Products Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Human Blood Products Market report?

Ans: The Applications covered in the Human Blood Products Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Human Blood Products Market report?

Ans: The Types covered in the Human Blood Products Market report are Immune Globulin, Coagulation Factor, Albumin, Other

Recommended Reports

Blood Plasma Products

Blood Collection & Equipment

Hemostasis & Fractionation

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Blood Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Globulin
1.2.3 Coagulation Factor
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Human Blood Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Blood Products Market Perspective (2020-2031)
2.2 Global Human Blood Products Growth Trends by Region
2.2.1 Global Human Blood Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Human Blood Products Historic Market Size by Region (2020-2025)
2.2.3 Human Blood Products Forecasted Market Size by Region (2026-2031)
2.3 Human Blood Products Market Dynamics
2.3.1 Human Blood Products Industry Trends
2.3.2 Human Blood Products Market Drivers
2.3.3 Human Blood Products Market Challenges
2.3.4 Human Blood Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Blood Products Players by Revenue
3.1.1 Global Top Human Blood Products Players by Revenue (2020-2025)
3.1.2 Global Human Blood Products Revenue Market Share by Players (2020-2025)
3.2 Global Human Blood Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Human Blood Products Revenue
3.4 Global Human Blood Products Market Concentration Ratio
3.4.1 Global Human Blood Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Blood Products Revenue in 2024
3.5 Global Key Players of Human Blood Products Head office and Area Served
3.6 Global Key Players of Human Blood Products, Product and Application
3.7 Global Key Players of Human Blood Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Blood Products Breakdown Data by Type
4.1 Global Human Blood Products Historic Market Size by Type (2020-2025)
4.2 Global Human Blood Products Forecasted Market Size by Type (2026-2031)
5 Human Blood Products Breakdown Data by Application
5.1 Global Human Blood Products Historic Market Size by Application (2020-2025)
5.2 Global Human Blood Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Human Blood Products Market Size (2020-2031)
6.2 North America Human Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Human Blood Products Market Size by Country (2020-2025)
6.4 North America Human Blood Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Blood Products Market Size (2020-2031)
7.2 Europe Human Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Human Blood Products Market Size by Country (2020-2025)
7.4 Europe Human Blood Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Blood Products Market Size (2020-2031)
8.2 Asia-Pacific Human Blood Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Human Blood Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Human Blood Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Blood Products Market Size (2020-2031)
9.2 Latin America Human Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Human Blood Products Market Size by Country (2020-2025)
9.4 Latin America Human Blood Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Blood Products Market Size (2020-2031)
10.2 Middle East & Africa Human Blood Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Human Blood Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Human Blood Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Human Blood Products Introduction
11.1.4 Takeda Revenue in Human Blood Products Business (2020-2025)
11.1.5 Takeda Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Human Blood Products Introduction
11.2.4 CSL Revenue in Human Blood Products Business (2020-2025)
11.2.5 CSL Recent Development
11.3 Grifols
11.3.1 Grifols Company Details
11.3.2 Grifols Business Overview
11.3.3 Grifols Human Blood Products Introduction
11.3.4 Grifols Revenue in Human Blood Products Business (2020-2025)
11.3.5 Grifols Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Human Blood Products Introduction
11.4.4 Octapharma Revenue in Human Blood Products Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Kedrion
11.5.1 Kedrion Company Details
11.5.2 Kedrion Business Overview
11.5.3 Kedrion Human Blood Products Introduction
11.5.4 Kedrion Revenue in Human Blood Products Business (2020-2025)
11.5.5 Kedrion Recent Development
11.6 LFB Group
11.6.1 LFB Group Company Details
11.6.2 LFB Group Business Overview
11.6.3 LFB Group Human Blood Products Introduction
11.6.4 LFB Group Revenue in Human Blood Products Business (2020-2025)
11.6.5 LFB Group Recent Development
11.7 Biotest
11.7.1 Biotest Company Details
11.7.2 Biotest Business Overview
11.7.3 Biotest Human Blood Products Introduction
11.7.4 Biotest Revenue in Human Blood Products Business (2020-2025)
11.7.5 Biotest Recent Development
11.8 BPL
11.8.1 BPL Company Details
11.8.2 BPL Business Overview
11.8.3 BPL Human Blood Products Introduction
11.8.4 BPL Revenue in Human Blood Products Business (2020-2025)
11.8.5 BPL Recent Development
11.9 RAAS
11.9.1 RAAS Company Details
11.9.2 RAAS Business Overview
11.9.3 RAAS Human Blood Products Introduction
11.9.4 RAAS Revenue in Human Blood Products Business (2020-2025)
11.9.5 RAAS Recent Development
11.10 CBPO
11.10.1 CBPO Company Details
11.10.2 CBPO Business Overview
11.10.3 CBPO Human Blood Products Introduction
11.10.4 CBPO Revenue in Human Blood Products Business (2020-2025)
11.10.5 CBPO Recent Development
11.11 Hualan Bio
11.11.1 Hualan Bio Company Details
11.11.2 Hualan Bio Business Overview
11.11.3 Hualan Bio Human Blood Products Introduction
11.11.4 Hualan Bio Revenue in Human Blood Products Business (2020-2025)
11.11.5 Hualan Bio Recent Development
11.12 Tiantan Bio
11.12.1 Tiantan Bio Company Details
11.12.2 Tiantan Bio Business Overview
11.12.3 Tiantan Bio Human Blood Products Introduction
11.12.4 Tiantan Bio Revenue in Human Blood Products Business (2020-2025)
11.12.5 Tiantan Bio Recent Development
11.13 Shuanglin Bio
11.13.1 Shuanglin Bio Company Details
11.13.2 Shuanglin Bio Business Overview
11.13.3 Shuanglin Bio Human Blood Products Introduction
11.13.4 Shuanglin Bio Revenue in Human Blood Products Business (2020-2025)
11.13.5 Shuanglin Bio Recent Development
11.14 Boya Bio
11.14.1 Boya Bio Company Details
11.14.2 Boya Bio Business Overview
11.14.3 Boya Bio Human Blood Products Introduction
11.14.4 Boya Bio Revenue in Human Blood Products Business (2020-2025)
11.14.5 Boya Bio Recent Development
11.15 Yuanda Shuyang
11.15.1 Yuanda Shuyang Company Details
11.15.2 Yuanda Shuyang Business Overview
11.15.3 Yuanda Shuyang Human Blood Products Introduction
11.15.4 Yuanda Shuyang Revenue in Human Blood Products Business (2020-2025)
11.15.5 Yuanda Shuyang Recent Development
11.16 Weiguang Bio
11.16.1 Weiguang Bio Company Details
11.16.2 Weiguang Bio Business Overview
11.16.3 Weiguang Bio Human Blood Products Introduction
11.16.4 Weiguang Bio Revenue in Human Blood Products Business (2020-2025)
11.16.5 Weiguang Bio Recent Development
11.17 Nanyue Bio
11.17.1 Nanyue Bio Company Details
11.17.2 Nanyue Bio Business Overview
11.17.3 Nanyue Bio Human Blood Products Introduction
11.17.4 Nanyue Bio Revenue in Human Blood Products Business (2020-2025)
11.17.5 Nanyue Bio Recent Development
11.18 KM Biologics
11.18.1 KM Biologics Company Details
11.18.2 KM Biologics Business Overview
11.18.3 KM Biologics Human Blood Products Introduction
11.18.4 KM Biologics Revenue in Human Blood Products Business (2020-2025)
11.18.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Octapharma AG
Grifols S A
Hualan Bio
BPL
Takeda
CSL Limited
Kedrion S p A
LFB Group
Biotest
RAAS
CBPO
Tiantan Bio
Shuanglin Bio
Boya-Bio
Yuanda shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
List of Tables
 Table 1. Global Human Blood Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Immune Globulin
 Table 3. Key Players of Coagulation Factor
 Table 4. Key Players of Albumin
 Table 5. Key Players of Other
 Table 6. Global Human Blood Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Human Blood Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Human Blood Products Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Human Blood Products Market Share by Region (2020-2025)
 Table 10. Global Human Blood Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Human Blood Products Market Share by Region (2026-2031)
 Table 12. Human Blood Products Market Trends
 Table 13. Human Blood Products Market Drivers
 Table 14. Human Blood Products Market Challenges
 Table 15. Human Blood Products Market Restraints
 Table 16. Global Human Blood Products Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Human Blood Products Market Share by Players (2020-2025)
 Table 18. Global Top Human Blood Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Products as of 2024)
 Table 19. Ranking of Global Top Human Blood Products Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Human Blood Products Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Human Blood Products, Headquarters and Area Served
 Table 22. Global Key Players of Human Blood Products, Product and Application
 Table 23. Global Key Players of Human Blood Products, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Human Blood Products Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Human Blood Products Revenue Market Share by Type (2020-2025)
 Table 27. Global Human Blood Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Human Blood Products Revenue Market Share by Type (2026-2031)
 Table 29. Global Human Blood Products Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Human Blood Products Revenue Market Share by Application (2020-2025)
 Table 31. Global Human Blood Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Human Blood Products Revenue Market Share by Application (2026-2031)
 Table 33. North America Human Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Human Blood Products Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Human Blood Products Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Human Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Human Blood Products Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Human Blood Products Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Human Blood Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Human Blood Products Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Human Blood Products Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Human Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Human Blood Products Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Blood Products Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Human Blood Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Human Blood Products Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Human Blood Products Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Takeda Company Details
 Table 49. Takeda Business Overview
 Table 50. Takeda Human Blood Products Product
 Table 51. Takeda Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 52. Takeda Recent Development
 Table 53. CSL Company Details
 Table 54. CSL Business Overview
 Table 55. CSL Human Blood Products Product
 Table 56. CSL Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 57. CSL Recent Development
 Table 58. Grifols Company Details
 Table 59. Grifols Business Overview
 Table 60. Grifols Human Blood Products Product
 Table 61. Grifols Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 62. Grifols Recent Development
 Table 63. Octapharma Company Details
 Table 64. Octapharma Business Overview
 Table 65. Octapharma Human Blood Products Product
 Table 66. Octapharma Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 67. Octapharma Recent Development
 Table 68. Kedrion Company Details
 Table 69. Kedrion Business Overview
 Table 70. Kedrion Human Blood Products Product
 Table 71. Kedrion Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 72. Kedrion Recent Development
 Table 73. LFB Group Company Details
 Table 74. LFB Group Business Overview
 Table 75. LFB Group Human Blood Products Product
 Table 76. LFB Group Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 77. LFB Group Recent Development
 Table 78. Biotest Company Details
 Table 79. Biotest Business Overview
 Table 80. Biotest Human Blood Products Product
 Table 81. Biotest Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 82. Biotest Recent Development
 Table 83. BPL Company Details
 Table 84. BPL Business Overview
 Table 85. BPL Human Blood Products Product
 Table 86. BPL Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 87. BPL Recent Development
 Table 88. RAAS Company Details
 Table 89. RAAS Business Overview
 Table 90. RAAS Human Blood Products Product
 Table 91. RAAS Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 92. RAAS Recent Development
 Table 93. CBPO Company Details
 Table 94. CBPO Business Overview
 Table 95. CBPO Human Blood Products Product
 Table 96. CBPO Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 97. CBPO Recent Development
 Table 98. Hualan Bio Company Details
 Table 99. Hualan Bio Business Overview
 Table 100. Hualan Bio Human Blood Products Product
 Table 101. Hualan Bio Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 102. Hualan Bio Recent Development
 Table 103. Tiantan Bio Company Details
 Table 104. Tiantan Bio Business Overview
 Table 105. Tiantan Bio Human Blood Products Product
 Table 106. Tiantan Bio Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 107. Tiantan Bio Recent Development
 Table 108. Shuanglin Bio Company Details
 Table 109. Shuanglin Bio Business Overview
 Table 110. Shuanglin Bio Human Blood Products Product
 Table 111. Shuanglin Bio Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 112. Shuanglin Bio Recent Development
 Table 113. Boya Bio Company Details
 Table 114. Boya Bio Business Overview
 Table 115. Boya Bio Human Blood Products Product
 Table 116. Boya Bio Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 117. Boya Bio Recent Development
 Table 118. Yuanda Shuyang Company Details
 Table 119. Yuanda Shuyang Business Overview
 Table 120. Yuanda Shuyang Human Blood Products Product
 Table 121. Yuanda Shuyang Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 122. Yuanda Shuyang Recent Development
 Table 123. Weiguang Bio Company Details
 Table 124. Weiguang Bio Business Overview
 Table 125. Weiguang Bio Human Blood Products Product
 Table 126. Weiguang Bio Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 127. Weiguang Bio Recent Development
 Table 128. Nanyue Bio Company Details
 Table 129. Nanyue Bio Business Overview
 Table 130. Nanyue Bio Human Blood Products Product
 Table 131. Nanyue Bio Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 132. Nanyue Bio Recent Development
 Table 133. KM Biologics Company Details
 Table 134. KM Biologics Business Overview
 Table 135. KM Biologics Human Blood Products Product
 Table 136. KM Biologics Revenue in Human Blood Products Business (2020-2025) & (US$ Million)
 Table 137. KM Biologics Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Human Blood Products Picture
 Figure 2. Global Human Blood Products Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Blood Products Market Share by Type: 2024 VS 2031
 Figure 4. Immune Globulin Features
 Figure 5. Coagulation Factor Features
 Figure 6. Albumin Features
 Figure 7. Other Features
 Figure 8. Global Human Blood Products Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Human Blood Products Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. Other Case Studies
 Figure 13. Human Blood Products Report Years Considered
 Figure 14. Global Human Blood Products Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Human Blood Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Human Blood Products Market Share by Region: 2024 VS 2031
 Figure 17. Global Human Blood Products Market Share by Players in 2024
 Figure 18. Global Top Human Blood Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Products as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Human Blood Products Revenue in 2024
 Figure 20. North America Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Human Blood Products Market Share by Country (2020-2031)
 Figure 22. United States Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Human Blood Products Market Share by Country (2020-2031)
 Figure 26. Germany Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Human Blood Products Market Share by Region (2020-2031)
 Figure 34. China Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Human Blood Products Market Share by Country (2020-2031)
 Figure 42. Mexico Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Human Blood Products Market Share by Country (2020-2031)
 Figure 46. Turkey Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Human Blood Products Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Takeda Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 50. CSL Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 51. Grifols Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 52. Octapharma Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 53. Kedrion Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 54. LFB Group Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 55. Biotest Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 56. BPL Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 57. RAAS Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 58. CBPO Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 59. Hualan Bio Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 60. Tiantan Bio Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 61. Shuanglin Bio Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 62. Boya Bio Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 63. Yuanda Shuyang Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 64. Weiguang Bio Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 65. Nanyue Bio Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 66. KM Biologics Revenue Growth Rate in Human Blood Products Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Blood Product Market Insights Forecast to 2030
Global Blood Banking and Blood Products Market Research Report 2024
Human Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Plasma Protein Products Market Research Report 2024
Human Plasma Products and Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Protein Products Market Research Report 2024
Global Plasma derived Medical Product Market Research Report 2025
Blood Biological Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Serum Products Market Research Report 2024
Plasma derived Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Plasma Fractionation Product Market Research Report 2024
Global Blood and Blood Components Market Insights Forecast to 2030
Global Plasma derived Products Market Research Report 2025
Global Blood Plasma Fractionation Market Research Report 2025
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Plasma Derivative Market Research Report 2025
Global Plasma Fractionation Market Research Report 2025
Global Blood Plasma Fractionation Technology Market Research Report 2025
Global Human Blood Plasma Fractionation Market Research Report 2025
Global Blood Filter Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions